New Drug Design Avenues Targeting Alzheimer's Disease by Pharmacoinformatics-Aided Tools.
Ontology highlight
ABSTRACT: Neurodegenerative diseases (NDD) have been of great interest to scientists for a long time due to their multifactorial character. Among these pathologies, Alzheimer's disease (AD) is of special relevance, and despite the existence of approved drugs for its treatment, there is still no efficient pharmacological therapy to stop, slow, or repair neurodegeneration. Existing drugs have certain disadvantages, such as lack of efficacy and side effects. Therefore, there is a real need to discover new drugs that can deal with this problem. However, as AD is multifactorial in nature with so many physiological pathways involved, the most effective approach to modulate more than one of them in a relevant manner and without undesirable consequences is through polypharmacology. In this field, there has
SUBMITTER: Arrue L
PROVIDER: S-EPMC9503559 | biostudies-literature | 2022 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA